Randomized, Open-Label Phase II Study of Motesanib or Bevacizumab in Combination with Paclitaxel and Carboplatin (P/C) for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListBLUMENSCHEIN R. G., KABBINAVAR F. F., MENON H., MOK Shu Kam Tony, STEPHENSON J., BECK T. J., LAKSHMAIAH K., KRACHT K., SIKORSKI S. R., SCHWARTZBERG S. L.
Name of ConferenceASCO Annual Meeting 2010
Country/Region of ConferenceUnited States of America
Proceedings TitleASCO Annual Meeting 2010
Detailed descriptionorganized by American Society of Clinical Oncology,
Year2010
Month6
Place of PublicationUnited States of America
Pages7528
LanguagesEnglish-United Kingdom
KeywordsBevacizumab; Paclitaxel/carboplatin; NSCLC

Last updated on 2018-20-01 at 17:35